AMANDA ROSEWELL SHAW to Combined Modality Therapy
This is a "connection" page, showing publications AMANDA ROSEWELL SHAW has written about Combined Modality Therapy.
Connection Strength
0.458
-
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Mol Ther. 2017 11 01; 25(11):2440-2451.
Score: 0.425
-
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520.
Score: 0.033